logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (viii) All 'other drugs' inpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium14423002126026
Bulgaria0000000001414
Czech Republic1513011012113
Denmark03000000303
Germany15422052119510452145597
Estonia:::::::::::
Ireland12893632235439
Greece11010000303
Spain:::::::::::
France1::11::::1:
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary81214000025025
Malta:::::::::::
Netherlands15120100102232
Austria00100000101
Poland2:3:1:::::::
Portugal:::::::::::
Romania1278129121742459452181633
Slovenia:::::::::::
Slovakia00000000000
Finland00000000000
Sweden151251011328028
United Kingdom3::1:1::::1:
Croatia1710100::68:
Turkey33411210152035
Norway4112918172017102114339182
Total21439022516911354233612054961631
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

(4) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

The number of treatment clients in each country is listed in TDI-7

See also Table TDI-11 part(vii), part(viii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013